Search Results 861-870 of 19437 for autoimmune hepatitis

  1. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

  2. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

  3. Tofacitinib (oral route) - Mayo Clinic

    Liver disease, moderate—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Smoker, current or past—May ...

  4. Mayo Clinic Minute: Are you using a salt substitute?

    Fernandes says use caution if you have certain conditions, including, kidney, heart and liver disease, high blood pressure, and diabetes. Certain ...

  5. Kymberly D. Watt, M.D. - Mayo Clinic Faculty Profiles

    Watt also studies recurrent disease, including fatty liver disease and malignancies after liver transplantation. The primary goal of her research is to ...

  6. A Study to Measure Hemolysis Markers in Subjects with Warm Autoimmune Hemolytic Anemia - Mayo Clinic

    ... Autoimmune Hemolytic Anemia (wAIHA). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  7. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

  8. Metabolic syndrome - Symptoms & causes - Mayo Clinic

    Other conditions linked to metabolic syndrome include steatotic liver disease, polycystic ovary syndrome and sleep apnea. Diet and exercise. People who eat ...

  9. Ritlecitinib (oral route) - Side effects & dosage - Mayo Clinic

    Herpes zoster infection or; Tuberculosis, history of or; Weakened immune system—May cause side effects to become worse. Infection, active or; Liver disease, ...

  10. Cirrhosis - Doctors and departments - Mayo Clinic

    Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...